stockrowTeva Pharmaceutical Industries Ltd.
TEVA Healthcare Drug Manufacturers Specialty & Generic
Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.
- Revenue
- −1.90%
- EPS
- −47.2%
- Free cash flow
- −30.3%
- Total debt
- −0.43%
Quarter to September 2026, against a year earlier
Follow TEVA
Alert me
Teva Pharmaceutical Industries Ltd. (TEVA) Shares outstanding
Teva Pharmaceutical Industries Ltd.'s shares outstanding at the end of fiscal 2025 was $1.2B, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.2B. Over the past ten years it has ranged from $864.0M (fiscal 2015) to $1.2B (fiscal 2025) — the current reading is the highest in ten years. Teva Pharmaceutical Industries Ltd. ranks 3rd of 81 Drug Manufacturers Specialty & Generic companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $1.2B | 2.83% |
| FY2024 | $1.1B | 1.07% |
| FY2023 | $1.1B | 0.81% |
| FY2022 | $1.1B | 0.27% |
| FY2021 | $1.1B | 1.10% |
| FY2020 | $1.1B | 0.37% |
| FY2019 | $1.1B | 6.86% |
| FY2018 | $1.0B | 0.49% |
| FY2017 | $1.0B | 5.72% |
| FY2016 | $961.0M | 11.23% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $1.2B | 1.55% |
| Jun 2026 | $1.2B | (1.19%) |
| Mar 2026 | $1.2B | 1.38% |
| Dec 2025 | $1.2B | (0.09%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| HLN Haleon PLC Sponsored ADR compare | $4.6B |
| TAK Takeda Pharmaceutical Co. compare | $3.2B |
| TEVA Teva Pharmaceutical Industries Ltd. | $1.2B |
| VTRS Viatris Inc. compare | $1.2B |
| RDY Dr. Reddy's Laboratories Ltd compare | $833.3M |
| ELAN Elanco Animal Health Incorporated compare | $505.9M |
| ZTS Zoetis Inc. compare | $417.7M |
| NBIX Neurocrine Biosciences, Inc. compare | $105.2M |
| UTHR United Therapeutics Corporation compare | $45.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on TEVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement